Abbott Receives U.S. FDA Approval for Heat-Stable Norvir® (ritonavir) Tablets
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Roche study drug may offer valuable new treatment option for patients with type 2 diabetes
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Lilly's Online, Interactive Health Education Program Receives Two Web Awards
- Details
- Category: Eli Lilly and Company
![Lilly Lilly](http://www.worldpharmanews.com/images/stories/logo/lilly.gif)
Novartis gains exclusive rights to Debio 025
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
US FDA Approves New Indication for Crestor (Rosuvastatin Calcium)
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Denosumab Trial met Primary and all Secondary Endpoints
- Details
- Category: Amgen
![Amgen Amgen](http://www.worldpharmanews.com/images/stories/logo/amgen.gif)
Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness
- Details
- Category: Pfizer
![Pfizer Pfizer](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- GSK launches new specialist unit to research and develop medicines for rare diseases
- Strong operating performance for Roche in 2009
- Pfizer Reports Fourth-Quarter and Full-Year 2009 Results
- VYVANSE® - new ADHD treatment option - now available in Canada
- Roche establishes new medical research hub in Singapore
- Lilly Reports Fourth-Quarter and Full-Year 2009 Results
- AstraZeneca Fourth Quarter and Full Year Results 2009